1 / 10

Enzyme Inhibition in Drug Action: Strategies and Mechanisms

Explore enzyme inhibition in drug action, from enzyme malfunction to microbial enzyme introduction, reversible and irreversible inhibitors, and the design of enzyme-targeting drugs. Understand the intricacies of enzyme interactions for effective drug development.

pitman
Download Presentation

Enzyme Inhibition in Drug Action: Strategies and Mechanisms

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Enzyme Inhibition and Drug Action • Malfunction of enzyme • Introduction of enzyme by microorganism Disease Inhibition of enzyme - Interesting but difficult drug strategy Inhib. of enzymes from microorganisms - Enzyme only in microorg. - Different structure of enzyme, human and microorg

  2. Enzyme inhibition Two last steps ≈irreversible, E-S to E-P rate limiting Reaction velocity, V=k3 [E-S] Rate of form. ES: k1[E][S] Rate of decomp. ES: (k1 + k3)[E][S] Assume steady state ([E-S] doesn’t change) k1[E][S] = (k1 + k3)[E][S] Michaelis const.: KM = (k2 + k3) / k1 [E] = [E tot] - [E-S]

  3. V=k3 [E-S] Vmax: All enzyme sites occupied by S [S]>>KM, Vmax=k3 [Etot]

  4. Measure rate at different [S]: Determine KM and Vmax

  5. Reversible and irreversible enzyme inhibitors • Reversible inhibition • Competitive • Non-competitive If covalently bond to enzyme, bond relatively easily be broken i.e. hydrol. of ester Binding to the same site Inhib. can be reversed by increasing [S] Vmax unchanged KM increase Structural resemblance S and I Designed I drugs - Antimetabolites

  6. Ex. antimetabolites

  7. Ex. transition state analogs Also metab. of anticancer / antiviral adeninederiv.

  8. Reversible inhibition • Competitive • Non-competitive Binding to different sites Inhib. can be reversed by increasing [S] Vmax decrease KM unchanged Inhib. and substrate very different structures Difficult to design inhib.

  9. Irreversible enzyme inhibitors Often covalent bonds between E and I Enzyme is permanently modified and inactivated • Affinity labels and active site directed irreversible inhibitors • Mechanism based irreversible enzyme inactivators Structural recemblance with substrate Electrophilic - alkylate nucleophilic subst in enzyme active site Low selectivity - generally highly toxic

  10. Affinity labels and active site directed irreversible inhibitors • Mechanism based irreversible enzyme inactivators Suicide substrate - kcat inhibitors - Trojan horse inhib. - latent alkylating agent ≈ Pro-drug, must be activated by the enzyme

More Related